DSCSA 2023 stabilization period: Connections and credentials—all key to getting this right

 

The entirety of the drug manufacturing and distribution chain in the US has been implementing the Drug Supply Chain Security Act (DSCSA) for almost ten years. The final interoperable components have a deadline of November 27, 2023. However, the FDA has granted a stabilization period of one year for these elements. 

Manufacturers, wholesalers and distributors now have an extended period to verify data integrations, ensure credentials and authorized trading partners are established and test, test, test. This webinar will cover these essential topics, the state of integrations today, and the opportunities the industry has by being given this extended window.